Ido Agmon
Director/Board Member chez PURPLE BIOTECH LTD
Profil
Ido Agmon is currently an Independent Director at Purple Biotech Ltd.
He previously served as the Chief Executive Officer at Meytav Technological Enterprises Innovation Center Ltd.
from 2009 to 2011.
He also held director positions at EZ Orthopedics Ltd., SphinxTech Ltd., and CyToD Ltd.
Additionally, he was the Director of Business Development at ATI Ashkelon Technological Industries Ltd.
from 2007 to 2009.
Mr. Agmon has a background in business, having obtained an undergraduate degree from Tel-Aviv University and an MBA from The Hebrew University of Jerusalem.
Postes actifs de Ido Agmon
| Sociétés | Poste | Début |
|---|---|---|
| PURPLE BIOTECH LTD | Director/Board Member | 27/06/2016 |
Anciens postes connus de Ido Agmon
| Sociétés | Poste | Fin |
|---|---|---|
Aviv Bio-Invest
 Aviv Bio-Invest Financial ConglomeratesFinance Aviv Bio-Invest functions as an investment fund. The private company is based in Tel Aviv, Israel. | Corporate Officer/Principal | 01/01/2016 |
Meytav Technological Enterprises Innovation Center Ltd.
 Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona. | Chief Executive Officer | 31/12/2011 |
ATI Ashkelon Technological Industries Ltd.
 ATI Ashkelon Technological Industries Ltd. Investment ManagersFinance ATI Ashkelon Technological Industries Ltd (ATI) is a venture capital subsidiary of Gefen Biomed Investments Ltd founded in 1991. The firm is headquartered in Ashkelon, Israel. | Corporate Officer/Principal | 01/01/2009 |
Pep2Life Ltd.
 Pep2Life Ltd. Medical DistributorsDistribution Services Pep2Life Ltd. develops proprietary novel pro-angiogenic drugs to treat peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. It presents a novel strategy for therapeutic angiogenesis, which differs from current intervention and from stem cell-based programs in clinical development. Its lead product is a short synthetic peptide, ADoPep1 which targets a cell surface receptor, GRP78 which is only expressed under stress by endothelial cells. Pep2Life was founded in December 2010 and is headquartered in Hertzelia, Israel. | Director/Board Member | - |
SphinxTech Ltd.
 SphinxTech Ltd. Medical SpecialtiesHealth Technology SphinxTech Ltd. develops and manufactures medical devices. It focuses on the research and development of minimally invasive medical devices for the treatment of fecal incontinence. The company was founded in 2005 by Yehiel Ziv and Avinoam Nevler and is headquartered in Kiryat Shmona, Israel. | Chairman | - |
Formation de Ido Agmon
| Tel-Aviv University | Undergraduate Degree |
| The Hebrew University of Jerusalem | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PURPLE BIOTECH LTD | Health Technology |
| Entreprise privées | 7 |
|---|---|
Meytav Technological Enterprises Innovation Center Ltd.
Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona. | Finance |
EZ Orthopedics Ltd.
 EZ Orthopedics Ltd. Medical SpecialtiesHealth Technology EZ Orthopedics Ltd. develops medical orthopedics devices. It offers invasive orthopedic fasteners for soft tissue repair, bone fracture fixation, spinal stabilization and prosthetic support. The company was founded by Yosef Freedland in 2004 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
SphinxTech Ltd.
SphinxTech Ltd. Medical SpecialtiesHealth Technology SphinxTech Ltd. develops and manufactures medical devices. It focuses on the research and development of minimally invasive medical devices for the treatment of fecal incontinence. The company was founded in 2005 by Yehiel Ziv and Avinoam Nevler and is headquartered in Kiryat Shmona, Israel. | Health Technology |
CyToD Ltd.
 CyToD Ltd. Pharmaceuticals: MajorHealth Technology CyToD develops therapeutic approach to treat such chronic asthma and rheumatoid arthritis. It focuses on the pathways that restrict homing of specific subsets of immune cells to their activation sites in the lymph nodes and sites of inflammation and thereby fine tune the immune response. The company was founded by Idit Shachar and Liat Flaishon in 2008 and is headquartered in Tel Hai, Israel. | Health Technology |
ATI Ashkelon Technological Industries Ltd.
ATI Ashkelon Technological Industries Ltd. Investment ManagersFinance ATI Ashkelon Technological Industries Ltd (ATI) is a venture capital subsidiary of Gefen Biomed Investments Ltd founded in 1991. The firm is headquartered in Ashkelon, Israel. | Finance |
Pep2Life Ltd.
Pep2Life Ltd. Medical DistributorsDistribution Services Pep2Life Ltd. develops proprietary novel pro-angiogenic drugs to treat peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. It presents a novel strategy for therapeutic angiogenesis, which differs from current intervention and from stem cell-based programs in clinical development. Its lead product is a short synthetic peptide, ADoPep1 which targets a cell surface receptor, GRP78 which is only expressed under stress by endothelial cells. Pep2Life was founded in December 2010 and is headquartered in Hertzelia, Israel. | Distribution Services |
Aviv Bio-Invest
Aviv Bio-Invest Financial ConglomeratesFinance Aviv Bio-Invest functions as an investment fund. The private company is based in Tel Aviv, Israel. | Finance |
